"The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-ap"...
DOSAGE AND ADMINISTRATION
The dosage of FARESTON is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.
Dosage Forms And Strengths
Tablet is 60 mg, round, convex, unscored, uncoated, and white, or almost white, identified with TO 60 embossed on one side.
Storage And Handling
FARESTON Tablets, containing toremifene citrate in an amount equivalent to 60 mg of toremifene, are round, convex, unscored, uncoated, and white, or almost white.
FARESTON Tablets are identified with TO 60 embossed on one side.
FARESTON Tablets are available as:
NDC 11399-005-30 bottles of 30
NDC 11399-005-01 bottles of 100
NDC 11399-005-07 samples of 7
Store at 25°C (77°F).
Excursions permitted to 15-30°C (59-86°F)
[See USP Controlled Room Temperature.]
Protect from heat and light.
Distributed by GTx, Inc. Memphis, TN 38103, USA. Rev. 03/2011This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/3/2011
Additional Fareston Information
Fareston - User Reviews
Fareston User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.